Four promising newcomers win the first stage of Venture Kick
25.08.2016
Eyes on our winners of the latest first stage: INJEX, Personalized Cancer Vaccines, StethoMD and QuantActions. Those are the four projects which recently entered the Venture Kick program by winning CHF 10’000 each at it's first stage. Meet them now before they compete on the second stage, where Venture Kick will allow them to expand their project and compete for CHF 20'000.
 Oliver Schlatter from INJEX
|
 |
 Franz-Josef Obermair from Personalized Cancer Vaccines
|
|
 Pierre Starkov from StethoMD
|
|
 The team of QuantActions
|
|
INJEX develops solutions for the fast fabrication of complex plastic parts. When 3D printing is no longer sufficient and injection molding is too expensive.
Personalized Cancer Vaccines therapeutic cancer vaccines based on novel targets discovered using proprietary MCR screening platform. This technology allows fast and effective identification of cancer specific peptides and provides a strong basis for efficient therapeutic vaccine development.
StethoMD is the first-ever smartphone connected Stethoscope with sharing capabilities over live and recorded cardiopulmonary auscultations.
QuantActions provides the only secure, privacy-aware platform for analysis of tapping patterns on mobile devices. Its patented technology enables deep analysis of user activity for applications in multiple industries including healthcare, employee compliance, mobile app development and advertising. QuantActions technology is being used now in clinical studies.